Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -508.45% | 11.43% | 28.98% | 14.01% | -75.61% |
| Total Depreciation and Amortization | 2.99% | 1.74% | 1.77% | 1.80% | 1.83% |
| Total Amortization of Deferred Charges | 137.34% | -29.94% | -9.71% | 1.60% | 71.23% |
| Total Other Non-Cash Items | 1,928.66% | -14.11% | -23.15% | 26.00% | 43.20% |
| Change in Net Operating Assets | -109.38% | -127.28% | 19.59% | 0.88% | 574.22% |
| Cash from Operations | -127.27% | -1,032.98% | 120.41% | 45.33% | 8.06% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -75.59% | 3,500.00% | -- | -- |
| Cash from Investing | -414.46% | -75.59% | 3,500.00% | -- | -- |
| Total Debt Issued | 69.79% | 157.29% | -32.62% | -36.26% | 54.20% |
| Total Debt Repaid | -25.95% | 28.42% | -83.60% | 25.59% | -40.69% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 97.92% | 488.70% | -156.13% | -44.74% | 66.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -162.09% | -- | -- | -- | -- |